Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Enzyme-Linked Immunosorbent Assay (ELISA): A Global Strategic Business Report

Investments in immunology research aiding growth in the global ELISA market


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-04-16 06:03:01 - Enzyme-Linked Immunosorbent Assay (ELISA): A Global Strategic Business Report - a new market research report on companiesandmarkets.com

Global market for Research Enzyme-Linked Immunosorbent Assay (ELISA) is projected to reach US$141 million by 2018, driven by continuing technological advancements and increasing investments in research related to immunology and medicine.

Enzyme-Linked Immunosorbent Assay (ELISA) is one of the few assay formats to find widespread popularity in a rapidly changing life sciences and drug discovery market. However, over the last few years, the market has been witnessing negative growth due to the adoption of new technologies by researchers, particularly multiplex proteomic array platforms. The growing preference for multiplex proteomic arrays has been cannibalizing the popularity of ELISA. Growth in the market is thereby being restricted only to laboratories seeking cost-effective technology options. In addition to the competitive threat posed by multiplex

 

 

assays, manufacturers have been facing a major challenge in the form of increasing commoditization of ELISA products. Commoditization of ELISA products has intensified pricing pressures for manufacturers. To counter the challenges, manufacturers are targeting niche markets and are focusing on the development of innovative products.

Although the new multiplex proteomic array technology has dented sales of ELISA products, demand will continue to hold ground in the short to medium term owing in part to its use as a secondary validation process by multiplex customers. This is largely due to the quality and established credential of Research ELISA products. Cost-effective Research ELISA products are preferred by laboratories and researchers dealing with less number of analytes and high sensitivity of assays.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com